Department Manager for Molecular Pharmacology
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Hørsholm
is seeking a dedicated and experienced Department Manager to lead our Molecular Pharmacology department. The ideal candidate will possess proven leadership abilities and a passion for managing and developing teams, along with a background in molecular pharmacology and drug discovery.
The Molecular Pharmacology department plays an important role in supporting Gubra's peptide drug discovery initiatives by developing in vitro assays (cellular, non-cellular, enzymatic, etc.) to characterize novel peptide drug candidates. We are committed to delivering high-quality potency data and continuously integrating cutting-edge in vitro technologies to support Gubra's innovative and technological projects. Our team comprises of 5 scientists and 5 laboratory technicians who work collaboratively across the entire drug discovery value chain, engaging in both in-house and partnered projects.
In recent years, we have successfully developed highly automated workflows to enhance our drug screening platform, facilitating high-throughput peptide synthesis and data generation. This advancement has been achieved through close collaboration with the Chemistry and AI departments. The Molecular Pharmacology department is part of the larger In vitro & Pharmaceutical Research area, which includes Chemistry, Preformulation, Bioanalysis, Drug Formulation and Biomarker Assay.
As Department Manager your tasks include
Your competencies
As a person you
Please apply no later than May 12, 2024, by uploading your motivated cover letter and resume on our website. Please note that applications will be evaluated on a rolling basis. If you have questions about the position, please contact Director of In vitro & Pharmaceutical Research Anja Mosekjær Bengtsson at
About Gubra
Gubrais an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the fight for a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of +220 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!
The Molecular Pharmacology department plays an important role in supporting Gubra's peptide drug discovery initiatives by developing in vitro assays (cellular, non-cellular, enzymatic, etc.) to characterize novel peptide drug candidates. We are committed to delivering high-quality potency data and continuously integrating cutting-edge in vitro technologies to support Gubra's innovative and technological projects. Our team comprises of 5 scientists and 5 laboratory technicians who work collaboratively across the entire drug discovery value chain, engaging in both in-house and partnered projects.
In recent years, we have successfully developed highly automated workflows to enhance our drug screening platform, facilitating high-throughput peptide synthesis and data generation. This advancement has been achieved through close collaboration with the Chemistry and AI departments. The Molecular Pharmacology department is part of the larger In vitro & Pharmaceutical Research area, which includes Chemistry, Preformulation, Bioanalysis, Drug Formulation and Biomarker Assay.
As Department Manager your tasks include
- Daily management of a team of scientists and lab technicians to ensure high performance, personal development, well-being and engagement.
- Guide the team to accomplish department goals and objectives.
- Oversee the planning, execution, and analysis of experiments to support Gubra’s internal and partnered drug discovery projects.
- Engaging in collaborative interactions with other department managers and key internal stakeholders to ensure successful advancement of projects.
- Proactive lead in automatization and digitalization of processes within peptide potency screening and striving for continuous optimization.
- Support to Area Director and Executive Management to implement and execute the company strategy.
Your competencies
- Managerial experience preferably from the biotech/pharmaceutical industry.
- PhD or other equivalent experience within life sciences.
- Expertise in in vitro pharmacology or related in vitro methods.
- Proven involvement in drug discovery projects, demonstrating contributions across different phases.
- Ability to communicate clearly and concisely.
- Knowledge of laboratory automation and data management is beneficial.
As a person you
- Are passionate about developing people in a dynamic organization.
- Have a positive attitude that motivates people around you.
- Thrive on collaboration, innovation and delivering results.
- Engages in and promotes clear and open communication.
- Are proactive and able to initiate, focus and deliver on tasks and projects.
Please apply no later than May 12, 2024, by uploading your motivated cover letter and resume on our website. Please note that applications will be evaluated on a rolling basis. If you have questions about the position, please contact Director of In vitro & Pharmaceutical Research Anja Mosekjær Bengtsson at
About Gubra
Gubrais an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the fight for a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of +220 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!
Information og data
Denne ledige stilling har jobtypen "Apoteker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Hørsholm.
Jobbet er oprettet på vores service den 12.4.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Apoteker
- Hørsholm
- Søndag den 12. maj 2024
Lignende jobs
-
Apoteker i Lynge
Driven by the passion to improve quality of people’s lives, WS Audiology continues to grow as market leader in the hearing aid industry. With our commitment to increase penetration in an underserve..Få mere info- Apoteker
- Lynge
-
Apoteker i Frederikssund
Farmaceutkollega søges!Vi ønsker at opnormere vores farmaceutteam på Frederikssund Apotek og søger derfor en farmaceut til en fast stilling.Vil du være med til at videreudvikle Frederikssund, F..Få mere info- Apoteker
- Frederikssund
-
Apoteker i Klampenborg
Director Pharma Engineering, Eltronic / 1869 VirksomhedenEltronic A/S er en del af en større vision og et solidt fundament inden for Eltronic Group, etabler..Få mere info- Apoteker
- Klampenborg
-
Apoteker i Hillerød
Brænder du for det kliniknære, for at øge patientsikkerheden og vil du være med til at bidrage til udviklingen af klinisk farmaci på Nordsjællands Hospital? Du har nu mulighed for at bidrage ti..Få mere info- Apoteker
- Hillerød
Statistik over udbudte jobs som apotekere i Hørsholm
Herunder ser du udviklingen i udbudte apoteker i Hørsholm over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal apotekere.
Se flere statistikker her:
Statistik over udbudte apotekere over tid
| Dato | Alle jobs som apotekere |
|---|---|
| 3. juni 2024 | 2 |
| 2. juni 2024 | 2 |
| 1. juni 2024 | 2 |
| 31. maj 2024 | 2 |
| 30. maj 2024 | 2 |
| 29. maj 2024 | 2 |
| 28. maj 2024 | 2 |
| 27. maj 2024 | 2 |
| 26. maj 2024 | 2 |
| 25. maj 2024 | 2 |
| 24. maj 2024 | 2 |
| 23. maj 2024 | 2 |
| 22. maj 2024 | 2 |
| 21. maj 2024 | 2 |
| 20. maj 2024 | 2 |
| 19. maj 2024 | 2 |
| 18. maj 2024 | 2 |
| 17. maj 2024 | 2 |
| 13. maj 2024 | 1 |
| 12. maj 2024 | 1 |